This inventor holds 2 USPTO granted patents. Top assignee: Medarex Inc.. Active years: 2008-2012.
Company Filing History:
Years Active: 2008-2012
Title: Thomas Andrew Davis: Innovator in Cancer Treatment
Introduction
Thomas Andrew Davis is a notable inventor based in Clarksville, MD (US). He has made significant contributions to the field of medical treatment, particularly in the area of cancer therapy. With a total of 2 patents, his work focuses on innovative methods that utilize antibodies to combat serious health conditions.
Latest Patents
Davis's latest patents include groundbreaking methods of treatment using CTLA-4 antibodies. The first patent presents a method of treatment using human sequence antibodies against human CTLA-4 linked to a cytotoxic agent. This invention is particularly aimed at treating cancer and autoimmune diseases. The second patent also involves methods of treatment using human sequence antibodies against human CTLA-4, specifically targeting cancer treatment.
Career Highlights
Davis is currently associated with Medarex Inc., a company known for its advancements in biopharmaceuticals. His work at Medarex has allowed him to explore innovative solutions in the medical field, contributing to the development of effective treatments.
Collaborations
Throughout his career, Davis has collaborated with esteemed colleagues such as Tibor P Keler and Robert F Graziano. These partnerships have fostered a collaborative environment that enhances the research and development of new medical treatments.
Conclusion
Thomas Andrew Davis stands out as an influential inventor in the realm of cancer treatment, with a focus on innovative antibody therapies. His contributions through patents and collaborations continue to pave the way for advancements in medical science.